抗体探索の世界市場レポート 2025

抗体探索市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.3％で146億米ドルに成長します。予測期間における成長の背景には、抗体創薬サービスやプラットフォームに対する需要の増加、新規技術開発のための資金調達の急増、精密治療に対する需要の高まり、従来の治療的役割を超えた抗体の利用範囲の拡大などがあります。予測期間における主な動向としては、研究開発活動の活発化、モノクローナル抗体の需要拡大、先端技術の採用拡大、標的治療薬の需要拡大、新規抗体フォーマットの開発などが挙げられます。

抗体探索市場は、個別化治療薬としても知られる精密治療薬に対する需要の高まりにより、大きく成長する見込みです。このアプローチは、個々の患者の特性に合わせた治療を行い、効果を高めるものです。抗体探索は、疾患関連分子や細胞と正確に相互作用するモノクローナル抗体などの標的治療の開発を促進することで、精密治療において極めて重要な役割を果たしています。注目すべきは、2023年1月に食品医薬品局（FDA）の医薬品評価研究センター（CDER）が37の新規分子化合物（NME）を承認したことで、治療用NMEの約34％が個別化医薬品に分類されたことです。このことは、抗体探索市場の成長を牽引する精密治療薬の極めて重要な役割を裏付けています。

抗体探索市場の大手企業は、抗体開発プロセスを合理化し強化するために最先端技術に投資しています。注目すべきイノベーションの1つは、人工知能と計算技術を活用して抗体の同定と最適化を迅速化する、AIベースの計算抗体創薬プラットフォームの出現です。例えば、2023年10月、スウィフトファーマBVはAI主導の抗体探索プラットフォームを発表しました。このプラットフォームは、人工知能、ビッグデータ、機械学習、ファージディスプレイ技術を統合し、高特異性および高親和性の抗体-抗原結合を迅速に予測します。自然言語処理を模倣することで、このアプローチは多様な抗体バリエーションを生成し、これまでにない効率で包括的な抗体ライブラリー作製を可能にします。この先進的なシステムにより、抗体医薬の創製が大幅に加速されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界抗体探索PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の抗体探索市場：成長率分析
• 世界の抗体探索市場の実績：規模と成長, 2019-2024
• 世界の抗体探索市場の予測：規模と成長, 2024-2029, 2034F
• 世界抗体探索総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の抗体探索市場方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ファージディスプレイ
• ハイブリドーマ
• その他の方法
• 世界の抗体探索市場抗体の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヒト化抗体
• ヒト抗体
• キメラ抗体
• マウス抗体
• 世界の抗体探索市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬およびバイオテクノロジー業界
• 調査室
• 学術研究室
• 世界の抗体探索市場、ファージディスプレイのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 選択とスクリーニングの手法
• 最適化手法
• 世界の抗体探索市場ハイブリドーマのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• モノクローナル抗体の生産
• 審査および選考プロセス
• 世界の抗体探索市場、その他の方法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• トランスジェニックマウス技術
• B細胞工学
• 単一細胞選別技術

第7章 地域別・国別分析

• 世界の抗体探索市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の抗体探索市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 抗体探索市場：競合情勢
• 抗体探索市場：企業プロファイル
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
  • Sartorius AG Overview, Products and Services, Strategy and Financial Analysis
  • Charles River Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Bruker Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• WuXi Biologics
• Genmab A/S
• Evotec
• Cambrex corporation
• ChemPartner
• Aragen life science pvt ltd
• Genscript Technology Corporation
• Biocytogen
• Alcami corporation.Inc
• Twist Bioscience
• BioDuro-Sundia
• Fairjourney Biologics S.A
• Harbour BioMed
• Rockland Immunochemicals
• Creative Biolabs

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 抗体探索市場2029：新たな機会を提供する国
• 抗体探索市場2029：新たな機会を提供するセグメント
• 抗体探索市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Antibody discovery is the process of identifying and developing antibodies, which are proteins generated by the immune system to defend the body against harmful substances such as bacteria and viruses. Antibodies, also known as immunoglobulins, play a vital role in the immune response by recognizing and binding to specific molecules known as antigens.

The primary methods employed in antibody discovery include phage display, hybridoma, and others. Phage display is a molecular biology technique utilized for the study and selection of peptides or proteins, typically antibodies, that exhibit high affinity to a target of interest. This method is widely applied in antibody discovery to generate and select antibodies with specific binding properties. Various types of antibodies, including humanized antibodies, human antibodies, chimeric antibodies, and murine antibodies, find application among end users in the pharmaceutical and biotechnology industries, research laboratories, and academic institutions.

The antibody discovery research report is one of a series of new reports from The Business Research Company that provides antibody discovery market statistics, including the antibody discovery industry's global market size, regional shares, competitors with an Antibody discovery market share, detailed antibody discovery market segments, market trends and opportunities, and any further data you may need to thrive in the antibody discovery industry. This antibody discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The antibody discovery market size has grown rapidly in recent years. It will grow from $8.96 billion in 2024 to $9.87 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to surge in investment for drug discovery, growing investment in research and development activities, and presence of various healthcare research centers and academic institutions.

The antibody discovery market size is expected to see rapid growth in the next few years. It will grow to $14.6 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing demand for antibody drug discovery services and platforms, surge in funding for the development of novel technologies, growing demand for precision therapeutics, and broadening the utilization of antibodies beyond their conventional therapeutic roles. Major trends in the forecast period include increased research and development activities, growing demand for monoclonal antibodies, increased adoption of advanced technologies, growing demand for targeted therapeutics, and development of novel antibody formats.

The antibody discovery market is poised for significant growth due to the increasing demand for precision therapeutics, also known as personalized therapeutics. This approach tailors medical treatments to individual patient characteristics, enhancing effectiveness. Antibody discovery plays a pivotal role in precision therapeutics by facilitating the development of targeted therapies such as monoclonal antibodies, which interact precisely with disease-related molecules or cells. Notably, in January 2023, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% of therapeutic NMEs classified as personalized medicines. This underscores the pivotal role of precision therapeutics in driving the antibody discovery market's growth.

Leading players in the antibody discovery market are investing in cutting-edge technologies to streamline and enhance antibody development processes. One notable innovation is the emergence of AI-based computational antibody drug discovery platforms, which leverage artificial intelligence and computational techniques to expedite antibody identification and optimization. For example, in October 2023, SwiftPharma BV introduced an AI-driven antibody discovery platform. This platform integrates artificial intelligence, big data, machine learning, and phage display techniques to swiftly predict high-specificity and high-affinity antibody-antigen binding. By mimicking natural language processing, this approach generates diverse antibody variations, enabling comprehensive antibody library creation with unprecedented efficiency. This advanced system significantly accelerates the discovery of potential antibody drugs.

In July 2024, Pentixapharm, a Germany-based biotech company specializing in radiopharmaceuticals, acquired Glycotope's target discovery unit for an undisclosed sum. This acquisition supports Pentixapharm's strategy to enhance its oncology pipeline by converting preclinical antibodies targeting various cancer indications into radiopharmaceuticals. In addition to the preclinical assets, Pentixapharm acquired Glycotope's laboratories, cell banks, tumor target database, and equipment, thereby further enriching its Intellectual Property portfolio beyond the CXCR4 receptor. Glycotope, also based in Germany, is a biotechnology firm focused on developing glyco-optimized antibodies for cancer immunotherapies.

Major companies operating in the antibody discovery market report are Danaher Corporation, Eurofins Scientific, Sartorius AG, Charles River Laboratories, Bruker Corporation, WuXi Biologics, Genmab A/S, Evotec, Cambrex corporation, ChemPartner, Aragen life science Pvt ltd, Genscript Technology Corporation, Biocytogen, Alcami Corporation Inc, Twist Bioscience, BioDuro-Sundia, Fairjourney Biologics S.A, Harbour BioMed, Rockland Immunochemicals, Creative Biolabs, Synbio technologies, ImmunoPrecise, Ablexis, Myrio Therapeutics, Antibody Solutions, MabSilico

North America was the largest region in the antibody discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antibody discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The antibody discovery market includes revenues earned by entities by providing services such as antigen identification, immunization, antibody generation, screening, and characterization. The market value includes the value of related goods sold by the service provider or included within the service offering. The antibody discovery market also includes sales of antibody libraries, phage display kits, antigen proteins, and antibody screening platforms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antibody Discovery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antibody discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antibody discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antibody discovery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Methods: Phage Display; Hybridoma; Other Methods
• 2) By Antibody Type: Humanized Antibody; Human Antibody; Chimeric Antibody; Murine Antibody
• 3) By End Users: Pharmaceutical And Biotechnology Industry; Research Laboratory; Academic Laboratory
• Subsegments:
• 1) By Phage Display: Selection And Screening Techniques; Optimization Methods
• 2) By Hybridoma: Monoclonal Antibody Production; Screening And Selection Processes
• 3) By Other Methods: Transgenic Mouse Technology; B-Cell Engineering; Single-Cell Sorting Techniques
• Companies Mentioned: Danaher Corporation; Eurofins Scientific; Sartorius AG; Charles River Laboratories; Bruker Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Antibody Discovery Market Characteristics

3. Antibody Discovery Market Trends And Strategies

4. Antibody Discovery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Antibody Discovery Growth Analysis And Strategic Analysis Framework

• 5.1. Global Antibody Discovery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Antibody Discovery Market Growth Rate Analysis
• 5.4. Global Antibody Discovery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Antibody Discovery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Antibody Discovery Total Addressable Market (TAM)

6. Antibody Discovery Market Segmentation

• 6.1. Global Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Phage Display
• Hybridoma
• Other Methods
• 6.2. Global Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Humanized Antibody
• Human Antibody
• Chimeric Antibody
• Murine Antibody
• 6.3. Global Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Industry
• Research Laboratory
• Academic Laboratory
• 6.4. Global Antibody Discovery Market, Sub-Segmentation Of Phage Display, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Selection And Screening Techniques
• Optimization Methods
• 6.5. Global Antibody Discovery Market, Sub-Segmentation Of Hybridoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibody Production
• Screening And Selection Processes
• 6.6. Global Antibody Discovery Market, Sub-Segmentation Of Other Methods, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transgenic Mouse Technology
• B-Cell Engineering
• Single-Cell Sorting Techniques

7. Antibody Discovery Market Regional And Country Analysis

• 7.1. Global Antibody Discovery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Antibody Discovery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Antibody Discovery Market

• 8.1. Asia-Pacific Antibody Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Antibody Discovery Market

• 9.1. China Antibody Discovery Market Overview
• 9.2. China Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Antibody Discovery Market

• 10.1. India Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Antibody Discovery Market

• 11.1. Japan Antibody Discovery Market Overview
• 11.2. Japan Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Antibody Discovery Market

• 12.1. Australia Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Antibody Discovery Market

• 13.1. Indonesia Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Antibody Discovery Market

• 14.1. South Korea Antibody Discovery Market Overview
• 14.2. South Korea Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Antibody Discovery Market

• 15.1. Western Europe Antibody Discovery Market Overview
• 15.2. Western Europe Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Antibody Discovery Market

• 16.1. UK Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Antibody Discovery Market

• 17.1. Germany Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Antibody Discovery Market

• 18.1. France Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Antibody Discovery Market

• 19.1. Italy Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Antibody Discovery Market

• 20.1. Spain Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Antibody Discovery Market

• 21.1. Eastern Europe Antibody Discovery Market Overview
• 21.2. Eastern Europe Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Antibody Discovery Market

• 22.1. Russia Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Antibody Discovery Market

• 23.1. North America Antibody Discovery Market Overview
• 23.2. North America Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Antibody Discovery Market

• 24.1. USA Antibody Discovery Market Overview
• 24.2. USA Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Antibody Discovery Market

• 25.1. Canada Antibody Discovery Market Overview
• 25.2. Canada Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Antibody Discovery Market

• 26.1. South America Antibody Discovery Market Overview
• 26.2. South America Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Antibody Discovery Market

• 27.1. Brazil Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Antibody Discovery Market

• 28.1. Middle East Antibody Discovery Market Overview
• 28.2. Middle East Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Antibody Discovery Market

• 29.1. Africa Antibody Discovery Market Overview
• 29.2. Africa Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Antibody Discovery Market Competitive Landscape And Company Profiles

• 30.1. Antibody Discovery Market Competitive Landscape
• 30.2. Antibody Discovery Market Company Profiles
  • 30.2.1. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sartorius AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Charles River Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bruker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Antibody Discovery Market Other Major And Innovative Companies

• 31.1. WuXi Biologics
• 31.2. Genmab A/S
• 31.3. Evotec
• 31.4. Cambrex corporation
• 31.5. ChemPartner
• 31.6. Aragen life science pvt ltd
• 31.7. Genscript Technology Corporation
• 31.8. Biocytogen
• 31.9. Alcami corporation.Inc
• 31.10. Twist Bioscience
• 31.11. BioDuro-Sundia
• 31.12. Fairjourney Biologics S.A
• 31.13. Harbour BioMed
• 31.14. Rockland Immunochemicals
• 31.15. Creative Biolabs

32. Global Antibody Discovery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antibody Discovery Market

34. Recent Developments In The Antibody Discovery Market

35. Antibody Discovery Market High Potential Countries, Segments and Strategies

• 35.1 Antibody Discovery Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Antibody Discovery Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Antibody Discovery Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer